Monday, September 18, 2017 3:29:35 PM
James, on Discord a group of investors was calling SEC for answers in regards to Delcath's recent action moving to OTC.
As mentioned going dark is a way for a small company to delist without breaking the bank. But, SEC regulations stated clearly the company must file form 15, then follow by form 25 to notify the public as well as SEC that Delcath was going dark and delisting.
So we heard the company coming out saying they are going to voluntary delist and will be filing form 25 and then trade on OTC 10 days later. You saw they came out saying so. Then within 24 hours they came out saying negotiations with OTC allows them to immediately relist. Don't you think there is a reason behind this move?
Think about this, they were going to follow the SEC rule to file form 25 then suddenly they are bypassing SEC laws? I think not. They have to be able to do so without violations and going dark is not it because they are required to file form 15 for going dark and meet all requirements on form 15.
Therefore, the conclusion is that they aren't going dark because no form 15 was filed. Which means M&A is a very high probability at this point. Otherwise, I don't see how they are just bypassing SEC regulations. Plus Delaware corporate laws governs Delcath.
We're still digging into the legal aspect to try and confirm. I mean, if this was going to BK, don't you think Ren, Vanguard, and even Hudson Bay would have bailed by now?
There are other smaller holders too. We did not see a sell off by any of those guys except Aryton Captial with their 40 million shares way back.
As mentioned going dark is a way for a small company to delist without breaking the bank. But, SEC regulations stated clearly the company must file form 15, then follow by form 25 to notify the public as well as SEC that Delcath was going dark and delisting.
So we heard the company coming out saying they are going to voluntary delist and will be filing form 25 and then trade on OTC 10 days later. You saw they came out saying so. Then within 24 hours they came out saying negotiations with OTC allows them to immediately relist. Don't you think there is a reason behind this move?
Think about this, they were going to follow the SEC rule to file form 25 then suddenly they are bypassing SEC laws? I think not. They have to be able to do so without violations and going dark is not it because they are required to file form 15 for going dark and meet all requirements on form 15.
Therefore, the conclusion is that they aren't going dark because no form 15 was filed. Which means M&A is a very high probability at this point. Otherwise, I don't see how they are just bypassing SEC regulations. Plus Delaware corporate laws governs Delcath.
We're still digging into the legal aspect to try and confirm. I mean, if this was going to BK, don't you think Ren, Vanguard, and even Hudson Bay would have bailed by now?
There are other smaller holders too. We did not see a sell off by any of those guys except Aryton Captial with their 40 million shares way back.
Recent DCTH News
- Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts • Business Wire • 05/26/2026 08:01:00 PM
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/15/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:47:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:23:52 PM
- Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference • Business Wire • 05/12/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:12:12 PM
- Delcath Systems Reports First Quarter 2026 Results and Business Highlights • Business Wire • 05/07/2026 12:00:00 PM
- Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 • Business Wire • 05/07/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
